The BMT Data Book
2nd Edition
Published on 26. February 2009
Book
Paperback/Softback
544 pages
978-0-521-71100-5 (ISBN)
Description
The BMT Data Book is an essential guide to the data, outcome studies and complex decision-making processes involved in blood and marrow stem cell transplantation. Organized according to types of diseases and procedures, it contains more than hundred tables, figures and algorithms that reflect up-to-date research and give guidance on the choices between stem cell versus bone marrow transplantation, autologous versus allogeneic transplantation, and conventional versus experimental treatments. This new edition summarizes research of the last 5 years and gives mature data for all established indications, such as acute myeloid leukemia, myelodysplastic syndromes, Hodgkin's and Non-Hodgkin's lymphomas. In addition, controversies and new indications - like renal cell cancer and autoimmune disorders - are discussed plus new drugs and therapies, new stem cell sources (cord blood), new transplant protocols (reduced-intensity conditioning), and a guide to electronic databases.
More details
Edition
2nd Revised edition
Language
English
Place of publication
Cambridge
United Kingdom
Target group
Professional and scholarly
Edition type
Revised edition
Product notice
Paperback (trade)
Dimensions
Height: 234 mm
Width: 155 mm
Thickness: 25 mm
Weight
900 gr
ISBN-13
978-0-521-71100-5 (9780521711005)
Copyright in bibliographic data and cover images is held by Nielsen Book Services Limited or by the publishers or by their respective licensors: all rights reserved.
Schweitzer Classification
Other editions
New editions
Reinhold Munker | Gerhard C. Hildebrandt | Hillard M. Lazarus
The BMT Data Book
Including Cellular Therapy
Book
02/2013
3rd Edition
Cambridge University Press
€138.80
Shipment within 15-20 days
Additional editions
Reinhold Munker | Hillard M. Lazarus | Kerry Atkinson
The BMT Data Book
E-Book
05/2009
2nd Edition
Cambridge University Press
€67.99
Available for download
Previous edition
Book
12/2006
Cambridge University Press
€74.28
Article exhausted; check for reprint
Persons
Reinhold Munker is Associate Professor of Medicine, Department of Medicine, Division of Hematology/Oncology, Louisiana State University Health Sciences Center, USA. Hillard M. Lazarus is Professor of Medicine, Case Western Reserve University and Director, Blood and Marrow Transplant Program, University Hospitals Case Medical Center, USA. Kerry Atkinson is Professor of Medicine, University of Queensland, Director of Allogeneic Stem Cell Therapies, Director, Mater Health Services Cell Therapy Quality Management System and Head, Biotherapy Program, Mater Medical Research Institute, Mater Adult Hospital, Australia.
Content
Preface; Introduction; Part I. Basic Science: 1. Basic science; Part II. Hematologic Malignancies: 2. Therapeutic decision making in BMT/SCT for acute myeloid leukemia; 3. Therapeutic decision making in BMT/SCT for acute lymphoblastic leukemia; 4. Therapeutic decision making in BMT/SCT for chronic myeloid leukemia and other myeloproliferative syndromes; 5. Therapeutic decision making in BMT/SCT for chronic lymphatic leukemia; 6. Therapeutic decision making in BMT/SCT for myelodysplasia; 7. Therapeutic decision making in BMT/SCT for non-Hodgkin's lymphoma; 8. Therapeutic decision making in BMT/SCT for Hodgkin's lymphoma; 9. Therapeutic decision making in BMT/SCT for multiple myeloma; 10. Therapeutic decision making in BMT/SCT for amyloidosis; Part III. Solid Tumors: 11. Therapeutic decision making in SCT for breast cancer; 12. Therapeutic decision making in BMT/ SCT for non-seminomatous germ cell tumor of testis (nsgct); 13. Therapeutic decision making in SCT for renal cell cancer; 14. Therapeutic decision making in SCT for soft tissue sarcomas; Part IV. Non-malignant Disorders: 15. Therapeutic decision making in BMT/SCT for severe aplastic anemia; 16. Therapeutic decision making in BMT/SCT for congenital immunodeficiencies; 17. Therapeutic decision making in BMT/SCT for hemoglobinopathies; 18. Therapeutic decision making in BMT/SCT for autoimmune disorders; Part V. Practical Aspects and Procedures: 19. Practical aspects, including conditioning protocols and haploidentical transplantation; 20. Cord blood transplantation; Part VI. Complications: 21. Patho-biology of Graft-versus-host disease; 22. Diagnosis and treatment of graft-versus host disease; 23. Infectious complications; 24. Organ-related and miscellaneous complications; Part VII. The BMT/SCT Pharmacopoeia: 25. The BMT/SCT pharmacopoeia; Part VIII. HLA-testing and Laboratory Medicine: 26. HLA-testing and laboratory medicine: Appendix: Guide to the internet and other databases; Index.